Overview

Phase II Study of Weekly Paclitaxel (BMS-181339) in Patient With Breast Cancer

Status:
Completed
Trial end date:
2005-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and the safety of paclitaxel given weekly in patients with advanced or recurrent breast cancer
Phase:
Phase 2
Details
Lead Sponsor:
Bristol-Myers Squibb
Treatments:
Albumin-Bound Paclitaxel
Paclitaxel